1. Home
  2. Analysis
  3. Lupron
  4. Basaglar

Lupron and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lupron (leuprolide acetate) and Basaglar (insulin glargine). Common drug interactions include disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Lupron and Basaglar. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Lupron?

Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Jul, 10, 2026

16 people who take Lupron and Basaglar together, and have interactions are studied.

Lupron and Basaglar drug interactions.

What are the common drug interactions of Lupron and Basaglar, by gender? *:

female:

n/a

male:

  1. Disease progression
  2. Blood glucose increased
  3. Dyspnoea (difficult or laboured respiration)
  4. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Hand deformity
  7. Hepatic enzyme increased
  8. Hospitalisation
  9. Insomnia (sleeplessness)
  10. Loss of consciousness

What are the common drug interactions of Lupron and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Disease progression
  2. Hepatic enzyme increased

60+:

  1. Blood glucose increased
  2. Death
  3. Hospitalisation
  4. Insomnia (sleeplessness)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Pericardial effusion (fluid around the heart)
  7. Peripheral swelling
  8. Trigger finger
  9. Dyspepsia (indigestion)
  10. Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

  1. Prostate Cancer: 6 people, 37.50%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 31.25%
  3. Hairy Cell Leukaemia (a type of blood cancer): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lupron and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lupron and Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lupron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lupron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate and insulin glargine (the active ingredients of Lupron and Basaglar, respectively), and Lupron and Basaglar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.